跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Omekhriz 40 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Omekhriz 40
Approved
STANDARD
Omekhriz 40
Reyoung Pharmaceutical Co., Ltd..
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
f4b0de2925c830fa
Company
Reyoung Pharmaceutical Co., Ltd..
Type
Standard
Approval Details
Approval Id
f4b0de2925c830fa
Drug Approval Philippines Name
Omekhriz 40
Product Name
Omekhriz 40
Registration Number
DR-XY47900
Brand Name
Omekhriz 40
Generic Name
Omeprazole (as sodium)
Dosage Form
Lyophilized Powder for Injection (IV)
Dosage Strength
40 mg
Manufacturer
Reyoung Pharmaceutical Co., Ltd..
Importer
Khriz Pharma Trading, Inc.
Distributor
Khriz Pharma Trading, Inc.
Issuance Date
29 May 2024
Expiry Date
05 April 2027
Pharmacologic Category
Proton Pump Inhibitor (PPI)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
f4b0de2925c830fa
Type
Standard
Back to Philippines FDA Approvals